Don't miss out on Tuesday 29th October 2024, when Novartis AG (NYSE: NVS) will disclose its third quarter financial results before market open. Investors will have the chance to learn more about the company's performance during the quarter.
In accordance with the forecasts of financial specialists on Wall Street, the organization is primed to announce an anticipated $1.96 profit per share for the quarter. Additionally, the company is projected to reveal a total revenue of $12.76 billion for this particular period.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $50.17 billion. Additionally, they forecast the earnings per share to hit profit of $7.54 for the fiscal year.
Upon revisiting the corresponding quarter from the prior year, the company's earnings report demonstrated a per-share income of $1.74. This figure was attributed to the company's total revenue, which reached an impressive $11.78 billion during that same period.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $1.97 | +7.7% | 12.51 B | -8.1% |
| Q1 2024 | $1.80 | +5.3% | 11.83 B | -8.7% |
| Q4 2023 | $1.53 | +0.7% | 11.42 B | -10.0% |
| Q3 2023 | $1.74 | +10.1% | 11.78 B | -6.1% |
| Q2 2023 | $1.83 | +17.3% | 13.62 B | +6.6% |
| *Growth on year-over-year basis | ||||
Novartis AG (NVS) closed Friday's regular trading session at $113.79, reflecting a 0.58 percent increase, with a volume of 904.00 thousand shares.
